These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 29867443)
21. Biomarkers for Early Diagnostic of Mild Cognitive Impairment in Type-2 Diabetes Patients: A Multicentre, Retrospective, Nested Case-Control Study. Xu ZP; Yang SL; Zhao S; Zheng CH; Li HH; Zhang Y; Huang RX; Li MZ; Gao Y; Zhang SJ; Zhan PY; Zhang LF; Deng L; Wei S; Liu YC; Ye JW; Ren HJ; Li N; Kong CX; Wang X; Fang L; Zhou QZ; Jiang HW; Li JR; Wang Q; Ke D; Liu GP; Wang JZ EBioMedicine; 2016 Mar; 5():105-13. PubMed ID: 27077117 [TBL] [Abstract][Full Text] [Related]
22. Increased Serum Trimethylamine N-Oxide Level in Type 2 Diabetic Patients with Mild Cognitive Impairment. Xu N; Wan J; Wang C; Liu J; Qian C; Tan H Diabetes Metab Syndr Obes; 2022; 15():2197-2205. PubMed ID: 35923251 [TBL] [Abstract][Full Text] [Related]
23. Risk factors and metabolomics of mild cognitive impairment in type 2 diabetes mellitus. Luo T; Jiang X; Xu N; Zhao X; Xie X; Xia X; Bian X; Liu H Front Mol Biosci; 2024; 11():1341290. PubMed ID: 38698772 [No Abstract] [Full Text] [Related]
24. Occurrence of mild cognitive impairment with hyperinsulinaemia in Africans with advanced type 2 diabetes mellitus. Bashir J; Yarube IU IBRO Neurosci Rep; 2022 Jun; 12():182-187. PubMed ID: 35746970 [TBL] [Abstract][Full Text] [Related]
25. Increased Ratio of Global Huang R; Tian S; Han J; Cai R; Lin H; Guo D; Wang J; Wang S Front Physiol; 2019; 10():110. PubMed ID: 30837891 [No Abstract] [Full Text] [Related]
26. Prevalence, Influence Factors and Cognitive Characteristics of Mild Cognitive Impairment in Type 2 Diabetes Mellitus. Li W; Sun L; Li G; Xiao S Front Aging Neurosci; 2019; 11():180. PubMed ID: 31417393 [No Abstract] [Full Text] [Related]
27. In Addition to Poor Glycemic Control, a High Level of Irisin in the Plasma Portends Early Cognitive Deficits Clinically in Chinese Patients With Type 2 Diabetes Mellitus. Lin H; Yuan Y; Tian S; Han J; Huang R; Guo D; Wang J; An K; Wang S Front Endocrinol (Lausanne); 2019; 10():634. PubMed ID: 31572306 [No Abstract] [Full Text] [Related]
28. Efficacy and safety assessment of acupuncture and nimodipine to treat mild cognitive impairment after cerebral infarction: a randomized controlled trial. Wang S; Yang H; Zhang J; Zhang B; Liu T; Gan L; Zheng J BMC Complement Altern Med; 2016 Sep; 16(1):361. PubMed ID: 27623621 [TBL] [Abstract][Full Text] [Related]
29. Correlations of serum leptin and leptin resistance with depression and anxiety in patients with type 2 diabetes. Cernea S; Both E; Huţanu A; Şular FL; Roiban AL Psychiatry Clin Neurosci; 2019 Dec; 73(12):745-753. PubMed ID: 31404477 [TBL] [Abstract][Full Text] [Related]
30. Association of Serum Melatonin Level with Mild Cognitive Impairment in Type 2 Diabetic Patients: A Cross-Sectional Study. Zhang J; Lu J; Zhu H; Zhou X; Wei X; Gu M Int J Endocrinol; 2021; 2021():5566019. PubMed ID: 34007273 [TBL] [Abstract][Full Text] [Related]
31. Phase Lag Index of Resting-State EEG for Identification of Mild Cognitive Impairment Patients with Type 2 Diabetes. Kuang Y; Wu Z; Xia R; Li X; Liu J; Dai Y; Wang D; Chen S Brain Sci; 2022 Oct; 12(10):. PubMed ID: 36291332 [TBL] [Abstract][Full Text] [Related]
32. Increased Plasma Level of 24S-Hydroxycholesterol and Polymorphism of CYP46A1 SNP (rs754203) Are Associated With Mild Cognitive Impairment in Patients With Type 2 Diabetes. Shi J; Jia J; Tian S; Zhang H; An K; Zhu W; Cao W; Yuan Y; Wang S Front Aging Neurosci; 2021; 13():619916. PubMed ID: 34054500 [TBL] [Abstract][Full Text] [Related]
33. Montreal Cognitive Assessment Memory Index Score (MoCA-MIS) as a predictor of conversion from mild cognitive impairment to Alzheimer's disease. Julayanont P; Brousseau M; Chertkow H; Phillips N; Nasreddine ZS J Am Geriatr Soc; 2014 Apr; 62(4):679-84. PubMed ID: 24635004 [TBL] [Abstract][Full Text] [Related]
34. Serum Insulin Degrading Enzyme Level and Other Factors in Type 2 Diabetic Patients with Mild Cognitive Impairment. Sun J; Xia W; Cai R; Wang P; Huang R; Sun H; Tian S; Dong X; Wang S Curr Alzheimer Res; 2016; 13(12):1337-1345. PubMed ID: 27306699 [TBL] [Abstract][Full Text] [Related]
35. Mutations in the human leptin and leptin receptor genes as models of serum leptin receptor regulation. Lahlou N; Issad T; Lebouc Y; Carel JC; Camoin L; Roger M; Girard J Diabetes; 2002 Jun; 51(6):1980-5. PubMed ID: 12031989 [TBL] [Abstract][Full Text] [Related]
36. Diagnosis of TCM symptoms and analysis of risk factors of mild cognitive impairment in patients with type 2 diabetes mellitus. Fu X; Wang J; Zhang P; Du H; Wu S; Zhang H; Xiong W Am J Transl Res; 2021; 13(11):12980-12987. PubMed ID: 34956514 [TBL] [Abstract][Full Text] [Related]
37. Type 2 diabetes mellitus might be a risk factor for mild cognitive impairment progressing to Alzheimer's disease. Li W; Wang T; Xiao S Neuropsychiatr Dis Treat; 2016; 12():2489-2495. PubMed ID: 27729793 [TBL] [Abstract][Full Text] [Related]
38. The association of short-term memory and cognitive impairment with ghrelin, leptin, and cortisol levels in non-diabetic and diabetic elderly individuals. Sang YM; Wang LJ; Mao HX; Lou XY; Zhu YJ Acta Diabetol; 2018 Jun; 55(6):531-539. PubMed ID: 29492658 [TBL] [Abstract][Full Text] [Related]
39. Reduced Serum Levels of Klotho are Associated with Mild Cognitive Impairment in Patients with Type 2 Diabetes Mellitus. Zhang H; Yu L; Yun G Diabetes Metab Syndr Obes; 2023; 16():129-137. PubMed ID: 36760583 [TBL] [Abstract][Full Text] [Related]
40. Elevated adiponectin but varied response in circulating leptin levels to falciparum malaria in type 2 diabetics and non-diabetic controls. Acquah S; Eghan BA; Boampong JN Biomed J; 2016 Oct; 39(5):346-353. PubMed ID: 27884381 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]